Skip to main content
Top
Published in: Archives of Dermatological Research 9/2009

01-09-2009 | Short Communication

Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma

Authors: Natasa Colovic, Vladimir Jurisic, Tatjana Terzic, Henry Dushan Atkinson, Milica Colovic

Published in: Archives of Dermatological Research | Issue 9/2009

Login to get access

Abstract

The case of a 44-year-old man with a primary cutaneous large B-cell non-Hodgkin’s lymphoma of the scalp is reported. His mother died of gastric lymphoma and his sib brother is in a 20-year remission of T-cell lymphoma. The patient presented with a 16-year history of occipital and parietal alopecia and a recently worsening scalp rash. The histopathology and immunohistochemistry performed in April 2006 indicated a bcl-6+, MUM− and bcl-2−, primary cutaneous follicle center B-cell non-Hodgkin’s lymphoma, with an aggressive transformation to a diffuse large B-cell lymphoma. Bone marrow biopsy and CT chest, abdomen, and pelvis were negative for systemic lymphoma. The patient had an excellent clinical and histological resolution following 8 cycles of rituximab and CHOP protocol immunochemotherapy, and remains in complete remission until now. The protracted indolent phase of the disease, the familial history of lymphoma, the histological aggressive features and the patient’s excellent response to immunochemotherapy all contribute to a very unusual manifestation of this disease.
Literature
1.
go back to reference Altieri A, Lorenzo Bermejo J, Hemminki K (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106:668–672. doi:10.1182/blood-2005-01-0140 PubMedCrossRef Altieri A, Lorenzo Bermejo J, Hemminki K (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106:668–672. doi:10.​1182/​blood-2005-01-0140 PubMedCrossRef
2.
go back to reference Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe E, Dummer R, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R, Meijer CJ, Pimpinelli N, Ralfkiaer E, Russell-Jones R, Sander C, Santucci M, Sterry W, Swerdlow SH, Vermeer MH, Wechsler J, Whittaker S (2005) WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32(10):647–674. doi:10.1111/j.0303-6987.2005.00495.x PubMedCrossRef Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe E, Dummer R, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R, Meijer CJ, Pimpinelli N, Ralfkiaer E, Russell-Jones R, Sander C, Santucci M, Sterry W, Swerdlow SH, Vermeer MH, Wechsler J, Whittaker S (2005) WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32(10):647–674. doi:10.​1111/​j.​0303-6987.​2005.​00495.​x PubMedCrossRef
3.
4.
go back to reference Jaffe ES, Harris NL, Stein H, Vardiman JWE (eds) (2001) World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, PA Jaffe ES, Harris NL, Stein H, Vardiman JWE (eds) (2001) World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, PA
6.
go back to reference Pandolfino TL, Siegel RS, Kuzel TM, Rosen ST, Guitart J (2000) Primary cutaneous B cell lymphoma: review and current concepts. J Clin Oncol 18:2152–2168PubMed Pandolfino TL, Siegel RS, Kuzel TM, Rosen ST, Guitart J (2000) Primary cutaneous B cell lymphoma: review and current concepts. J Clin Oncol 18:2152–2168PubMed
7.
go back to reference Piccino R, Caccialanza M, Berti E, Baldini L (1993) Radiotherapy of cutaneous B-cell lymphoma. Int J Radiat Oncol Biol Phys 27:385–389 Piccino R, Caccialanza M, Berti E, Baldini L (1993) Radiotherapy of cutaneous B-cell lymphoma. Int J Radiat Oncol Biol Phys 27:385–389
10.
go back to reference Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Roodriquez AM, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F (2001) Primary cutaneous non-Hodgkin’s lymphoma of Ann Arbor Stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy. J Clin Oncol 19(2):398–405PubMed Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Roodriquez AM, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F (2001) Primary cutaneous non-Hodgkin’s lymphoma of Ann Arbor Stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy. J Clin Oncol 19(2):398–405PubMed
11.
go back to reference Visco C, Medeiros LJ, Jones D, Smith T, Rodriguez MA, McLaughlin P, Romaguera J, Cabanillas F, Sarris HA (2002) Primary cutaneous non-Hodgkin’s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement. Ann Oncol 13:1290–1299. doi:10.1093/annonc/mdf206 PubMedCrossRef Visco C, Medeiros LJ, Jones D, Smith T, Rodriguez MA, McLaughlin P, Romaguera J, Cabanillas F, Sarris HA (2002) Primary cutaneous non-Hodgkin’s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement. Ann Oncol 13:1290–1299. doi:10.​1093/​annonc/​mdf206 PubMedCrossRef
12.
go back to reference Willemze R, Jaffe SE, Burg G, Ceroni L, Berti E, Swerdow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Dunkan LM, Grange F, Harris Lee N, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Wermeer MH, Wechler J, Whittaker S, Meijr JLMC (2005) WHO-EORTC classification for cutaneous lymphoma. Blood 105:3768–3785. doi:10.1182/blood-2004-09-3502 PubMedCrossRef Willemze R, Jaffe SE, Burg G, Ceroni L, Berti E, Swerdow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Dunkan LM, Grange F, Harris Lee N, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Wermeer MH, Wechler J, Whittaker S, Meijr JLMC (2005) WHO-EORTC classification for cutaneous lymphoma. Blood 105:3768–3785. doi:10.​1182/​blood-2004-09-3502 PubMedCrossRef
13.
go back to reference Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371PubMed Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371PubMed
Metadata
Title
Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma
Authors
Natasa Colovic
Vladimir Jurisic
Tatjana Terzic
Henry Dushan Atkinson
Milica Colovic
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Archives of Dermatological Research / Issue 9/2009
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-009-0967-1

Other articles of this Issue 9/2009

Archives of Dermatological Research 9/2009 Go to the issue